Australia AADC Deficiency Market Analysis

$3,000.00$7,500.00

  • Type: Rare Disease Area
  • Published : April 2021
  • Region: APAC
  • Country: Australia
  • Report ID : 4099

  • Format: PPT, PDF

Australian AADC-Deficiency Therapeutics Market: Segmented by Diagnosis, TherapeuticsRoute of Administration, and Distribution Channels – Size, Share, Impact, Growth, Trends, and Forecasts (2020 – 2028) 

Clear
SKU: 4099 Categories: ,

The Australian AADC-Deficiency Therapeutics Market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.  

The AADC deficiency is an ultra-rare autosomal recessive disease caused by a non-functional AADC enzyme, which normally synthesizes serotonin and dopamine, among other important compounds. As a result, patients with AADC deficiency lack crucial neurotransmitters, including serotonin, dopamine, norepinephrine, epinephrine, and melatonin, and have severe developmental and motor deficiencies. Symptom onset typically occurs during the first months of life. The majority of patients present a severe phenotype with early-onset hypotonia, oculogyric crises, ptosis, dystonia, hypokinesia, impaired development, and autonomic dysfunction, a few patients with a milder disease course are known. Patients with AADC deficiency also present with autonomic dysfunction that is characterized by impairment of the sympathetic regulation of heart rate and blood pressure, paroxysmal sweating, emotional instability, and sleep disturbance. This leads to a complex syndrome characterized by motor, behavioral and autonomic symptoms. 

The life expectancy of patients with severe AADC deficiency has been reported to be less than a decade. In patients identified with AADC deficiency where gender is reported, the distribution is estimated as; approximately 57% are male and 43% are female. As per the cases documented in the literature, the average age of symptom onset for AADC deficiency is 2.7 months. Despite the early onset of symptoms, the average age of diagnosis is 3.5 years.

Market Growth Drivers & Restraints 

The introduction of novel therapies, robust product pipeline, rising government initiatives for creating awareness regarding the AADC-deficiency diagnosis and its treatment, and its available therapeutic options are expected to significantly fuel the market growth over the forecast period.  

Additionally, changes in government policies, demand and supply of the market, government intervention programs and major market share are also playing an essential role to boost the market growth over the forecast period. Moreover, the rise in the number of patients suffering from AADC deficiency is likely to fuel the market growth during the forecast period. In addition, rise in healthcare expenses and government initiatives for the betterment of health. Increased R&D activities to counter AADC deficiency in children are more likely to propel the market demand during the forecast period. Increasing collaboration and technological advancements are projected to bring new growth avenues for market players during the forecast period.  

While the high cost of approved therapeutics and higher treatment rates hampers the market. 

TABLE OF CONTENTS
1. Australian AADC-Deficiency Therapeutics Market Overview………………………
A. Market Size
2. Market Growth Drivers and Restraints……………………………………….…
A. Robust Products Pipeline & Introduction of Novel Therapies
B. Rising Government Initiatives and Increased R&D Activities
C. Increasing Collaboration and Technological Advancements
D. High Cost of Therapeutics and Lower Treatment Rates
3. Major Types of AADC-Deficiency……………………………………………………
A. Folding Type
B. Catalytic Type
C. Folding and Catalytic Type
4. AADC-Deficiency Therapeutics Market Segmentation……………………………….
A. By Diagnosis
I. Physical Examination
II. Complete Blood Count Test
III. Measurement of Electrolyte Levels
IV. Magnetic Resonance Imaging (MRI)
V. Measurement of AADC-enzyme Levels
VI. Spinal Tap/ Lumbar Puncture
VII. Genetic Testing
B. By Therapeutics
I. Gene Replacement Therapy
II. Physiotherapy
III. Psychotherapy
IV. Dopamine Agonists
V. MAO Inhibitors
VI. Anticholinergic Agents
VII. Benzodiazepines
VIII. Selective Serotonin Reuptake Inhibitors (SSRIs)
C. By Route of Administration
I. Oral
II. Parenteral
D. By Distribution Channels
I. Retail Pharmacies
II. Hospital Pharmacies
III. Online Pharmacies
5. AADC-Deficiency Major Drugs Market Share………………………………
A. Market Analysis, Insights and Forecast – By Revenue Type
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles………………………………………………………………….
A. Boehringer Ingelheim Company overview, Product & Services, Strategies &
Financials
B. Novartis Company overview, Product & Services, Strategies & Financials
C. iX Biopharma Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………………………………
A. Policy changes and Reimbursement Scenario
9. Factors Driving Future Growth…………………………………………………………
A. New Trends and Development of AADC-Deficiency Therapeutics Market
B. Future Opportunities
10. Conclusion

By Diagnosis: 

Based on the diagnosis, the AADC-deficiency Therapeutics market can be bifurcated into physical examination, complete blood count test, measurement of electrolyte levels, magnetic resonance imaging (MRI), measurement of AADC-enzyme levels, spinal tap or lumbar punctures, genetic testing, and others. 

A complete clinical evaluation and a high index of suspicion are required to make the diagnosis. The evaluation of a child starts with a complete physical examination. Although many tests, such as a complete blood count, measurement of electrolyte levels, and magnetic resonance imaging of the brain are usually performed in the diagnostic workup of a child presenting with neurodevelopmental delay. Additionally, some other diagnostic tests typically involve a blood test taken to measure levels of the AADC-enzyme and a spinal tap or lumbar puncture to collect cerebrospinal fluid (CSF).  

By Therapeutics: 

In terms of therapeutics, the AADC-deficiency Therapeutics market is classified into  

  • gene replacement therapy 
  • physiotherapy 
  • speech therapy
  • dietary supplements therapy 
  • psychotherapy 
  • dopamine agonists 
  • monoamine oxidase (MAO) inhibitors 
  • pyridoxal phosphate 
  • pyridoxine 
  • anticholinergic agents 
  • folinic acid 
  • L-dopa with carbidopa 
  • L-dopa without carbidopa 
  • 5-hydroxytryptophan 
  • benzodiazepines 
  • melatonin 
  • selective serotonin reuptake inhibitors (SSRIs)

Current research and clinical trials in AADC deficiency are mostly focused on gene replacement therapy, which aims to replace the non-working gene. The gene replacement therapy is injected via a surgical procedure into an area of the brain called the putamen. Thus, gene replacement therapy is expected to witness maximum market share during the forecast period. 

By Route of Administration: 

Based on route of administration, the AADC-deficiency Therapeutics of the market can be segmented into oral, parenteral, and others. The parenteral route is anticipated to dominate this segment & is further projected to control its market share during the forecast period.  

By Distribution Channels: 

In terms of distribution channels, the AADC-deficiency Therapeutics market has been bifurcated into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment generated the highest revenue in 2020 and is anticipated to witness growth during the forecast period due to most of major products are prescription products, which is available in hospital pharmacies. 

Top Major Players 

The AADC-deficiency Therapeutics market is a niche segment and currently has only a few players in Australia, and these are planning to adopt various strategies to garner maximum market share. The inorganic and organic strategies will pave a way for the expansion of the business and customer base of market players. Major Players include Boehringer Ingelheim Pty Ltd., Southern Cross Pharma Pty Ltd., Novartis Pharmaceuticals Australia Pty Ltd., Boucher & Muir Pty Ltd., iX Biopharma Pty Ltd among others. 

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements